We are live on
!
Find out more
Vir Biotechnology
251 hedge funds and large institutions have $1.25B invested in Vir Biotechnology in 2026 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 117 increasing their positions, 41 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
185% more repeat investments, than reductions
Existing positions increased: 117 | Existing positions reduced: 41
130% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 30
80% more capital invested
Capital invested by funds: $698M → $1.25B (+$557M)
35% more call options, than puts
Call options by funds: $4.54M | Put options by funds: $3.36M
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
17.18% more ownership
Funds ownership: 83.24% → 100.42% (+17%)
15% more funds holding
Funds holding: 218 → 251 (+33)
Holders
251
Holders Change
+33
Holders Change %
+15.14%
% of All Funds
3.09%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.07%
New
69
Increased
117
Reduced
41
Closed
30
Calls
$4.54M
Puts
$3.36M
Net Calls
+$1.18M
Net Calls Change
-$194K
Top Buyers
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$21.9M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$16M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$14M |
| 4 |
Goldman Sachs
New York
|
+$13.4M |
| 5 |
BlackRock
New York
|
+$13.3M |
Top Sellers
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$17.3M |
| 2 |
O
OrbiMed
New York
|
-$14.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.66M |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$8.39M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.25M |
